Paracetamol: Uses and Risks

1202 Words3 Pages

1-Paracetamol ( PCT), acetaminophen or N-acetyl-p-aminophenol (APAP) is an acylated aromatic amide derived from aniline [1] [s073][so96089] .It has antipyretic and analgesic properties and it is a synthetic non-opioid.[3] In 1893, acetaminophen was first described as an analgesic and antypiretic.. [s17] In 1866, acetanilide, another derived from aniline, was discovered to have antipyretic properties and has started to be used to treat fever. However, it was proved to have toxicity. Thus, others derivatives from aniline such as paracetamol and phenacetin were assumed to be toxic as well. In 1887 phenacetin was discovered to have serious side effects including methaemoglobin formation and haemolytic anaemia. In 1893, acetaminophen was first described to be an analgesic and antypiretic [s17] and in 1948 paracetamol was found to be phenacetin’s and acetanilide’s metabolite which was responsible for the antipyretic and analgesic properties of these two compounds. [1] 2- Paracetamol is commonly used for acute musculoskeletal pains, acute headache, and fever[3][s03]. IV Acetaminophen can also be used with an opioid to improve overall analgesia in patients with postoperative pain. In addition, paracetamol can have an anti-emetic effect in postoperative nausea, if administered before, during or immediately after surgery. Orthopedic postoperative pain management can be treated with parenteral proparacetamol which is an inactive pro-drug of acetaminophen.[3] 3- It’s still not precise how paracetamol acts in the human body. It has been shown to have multiple actions mainly in the CNS. [2][3]Acetaminophen may inhibit the peroxidase sites of PGHS [2]and inhibit the peroxidase regeneration leading to an anti-inflammatory effect.[3] Rec... ... middle of paper ... ... ́ısa Mateus,b Ana Paula dos Santos,b Rui Moreira,b Eliandre de Oliveirac and Paula Gomesa,* aCIQUP, Departamento de Quı ́mica, Faculdade de Cieˆncias do Porto, P-4169-007 Porto, Portugal bCECF, Faculdade de Farma ́cia de Lisboa, P-1600-083 Lisboa, Portugal
cProteomics Platform, Barcelona Science Park, E-08028 Barcelona, Spain Received 2 December 2004; revised 21 January 2005; accepted 27 January 2005 5- OLHAR FONTE S09608 Bioorganic & Medicinal Chemistry Letters 20 (2010) 3851–3854 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Development of acetaminophen proline prodrug Zhiqian Wu *, Ashish Patel, Rutesh Dave, Xudong Yuan
Division of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY 11201, United States

More about Paracetamol: Uses and Risks

Open Document